GlassScriptPhysician profile
John Michael Barnett
NPI 1194240937
$5,250.80
in general payments reported to CMS, 2019-2025
15 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,249 · 2022: $1,593 · 2023: $1,490 · 2024: $415 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,408.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,085.57 | 2021-2025 | |
| Vanda Pharmaceuticals INC. | $309.05 | 2022-2023 | Hetlioz, Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $299.12 | 2021-2024 | Caplyta |
| Alkermes, INC. | $240.29 | 2021-2025 | Aristada, Vivitrol, Vivitrol |
| Teva Pharmaceuticals USA, INC. | $232.39 | 2022-2023 | Austedo, Austedo Xr, Uzedy |
| Neurocrine Biosciences, INC. | $216.48 | 2021-2023 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $189.95 | 2021-2024 | Abilify Maintena, Rexulti |
| Janssen Pharmaceuticals, INC | $167.83 | 2022-2023 | Spravato, Invega Sustenna, Invega Trinza |
| Biogen, INC. | $154.33 | 2022-2023 | |
| Axsome Therapeutics, INC. | $146.36 | 2025 | Auvelity |
| Lundbeck LLC | $116.35 | 2021-2023 | Rexulti |
| Novo Nordisk INC | $31.71 | 2023 | |
| Corium, LLC | $24.65 | 2023 | Azstarys |
| Almatica Pharma LLC | $21.11 | 2023 | Loreev Xr |
| Noven Therapeutics, LLC | $15.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Barnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.